(S)-4-Benzyl-2-(1,10-phenanthrolin-2-yl)-4,5-dihydrooxazole
98%
- Product Code: 233201
CAS:
2828438-15-7
| Molecular Weight: | 339.4 g./mol | Molecular Formula: | C₂₂H₁₇N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 571.3±30.0 °C(Predicted) | |
| Density: | 1.28±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, Sealed, Inert Gas |
Product Description:
Used as a chiral catalyst in asymmetric synthesis, particularly in enantioselective carbon-carbon bond-forming reactions. Its structure supports coordination with transition metals, making it effective in catalyzing reactions like asymmetric allylic alkylation and Diels-Alder cycloadditions. The oxazole and phenanthroline moieties enhance metal binding and stereocontrol, leading to high enantioselectivity in the synthesis of pharmaceutical intermediates and fine chemicals.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿9,660.00 |
+
-
|
| 250mg | 10-20 days | ฿19,060.00 |
+
-
|
(S)-4-Benzyl-2-(1,10-phenanthrolin-2-yl)-4,5-dihydrooxazole
Used as a chiral catalyst in asymmetric synthesis, particularly in enantioselective carbon-carbon bond-forming reactions. Its structure supports coordination with transition metals, making it effective in catalyzing reactions like asymmetric allylic alkylation and Diels-Alder cycloadditions. The oxazole and phenanthroline moieties enhance metal binding and stereocontrol, leading to high enantioselectivity in the synthesis of pharmaceutical intermediates and fine chemicals.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :